These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15143980)

  • 1. Opioid consumption in hospitals of the Friuli-Venezia Giulia region: a four-year retrospective study.
    Bortolussi R; Spazzapan S; Lombardi D; Colussi AM; Veronesi A; Matovic M; De Cicco M
    Tumori; 2004; 90(1):96-102. PubMed ID: 15143980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
    Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
    Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey.
    Salvato C; Aretini G; Serraglia D; Terrazzani G; Debetto P; Giusti P; Chinellato A
    Pharmacol Res; 2003 Jul; 48(1):75-82. PubMed ID: 12770518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain.
    Ravera E; Di Santo S; Bosco R; Arboscello C; Chiarlone R
    Aging Clin Exp Res; 2011; 23(5-6):328-32. PubMed ID: 22526067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan].
    Monje B; Giménez-Manzorro Á; Ortega-Navarro C; Herranz-Alonso A; Sanjurjo-Sáez M
    Braz J Anesthesiol; 2019; 69(3):259-265. PubMed ID: 30935672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.
    Botterman J; Criel N
    Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids for acute pancreatitis pain.
    Basurto Ona X; Rigau Comas D; Urrútia G
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009179. PubMed ID: 23888429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Quality of Life of Cancer Patients with Pain Treated with Oral Controlled-Release Morphine and Oxycodone and Transdermal Buprenorphine and Fentanyl.
    Leppert W; Nosek K
    Curr Pharm Des; 2019; 25(30):3216-3224. PubMed ID: 31333114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
    Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
    Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equipotent doses to switch from high doses of opioids to transdermal buprenorphine.
    Mercadante S; Casuccio A; Tirelli W; Giarratano A
    Support Care Cancer; 2009 Jun; 17(6):715-8. PubMed ID: 19104845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in trends and pattern of strong opioid prescribing in primary care.
    Zin CS; Chen LC; Knaggs RD
    Eur J Pain; 2014 Oct; 18(9):1343-51. PubMed ID: 24756859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accessibility of opioid analgesics and barriers to optimal chronic pain treatment in Poland in 2000-2015.
    Dzierżanowski T; Ciałkowska-Rysz A
    Support Care Cancer; 2017 Mar; 25(3):775-781. PubMed ID: 27771783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of transdermal fentanyl in pediatric oncology palliative care.
    Noyes M; Irving H
    Am J Hosp Palliat Care; 2001; 18(6):411-6. PubMed ID: 11712724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.